Package 60505-4379-3

{"route": ["ORAL"], "spl_id": "57998b73-87c9-7fed-ffa8-7e43620bd98a", "openfda": {"upc": ["0360505366835", "0360505437733", "0360505366934"], "unii": ["X2ELS050D8"], "rxcui": ["1738803", "1738804", "1738805", "1738806", "1738807", "1738808"], "spl_set_id": ["483bd97f-c4d0-4e23-aaa8-6334f4471e0c"], "manufacturer_name": ["Apotex Corp"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-4379-3)", "package_ndc": "60505-4379-3", "marketing_start_date": "20110101"}], "brand_name": "PAXIL CR", "product_id": "60505-4379_57998b73-87c9-7fed-ffa8-7e43620bd98a", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Serotonin Reuptake Inhibitor [EPC]", "Serotonin Uptake Inhibitors [MoA]"], "product_ndc": "60505-4379", "generic_name": "paroxetine hydrochloride", "labeler_name": "Apotex Corp", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PAXIL", "brand_name_suffix": "CR", "active_ingredients": [{"name": "PAROXETINE HYDROCHLORIDE", "strength": "37.5 mg/1"}], "application_number": "NDA020936", "marketing_category": "NDA", "marketing_start_date": "20110101", "listing_expiration_date": "20261231"}